Optimi Health Insider Trading
NEO OPTI
1
All Trades
0
Significant
1
Notable
0
Clusters
0
Repeat
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Optimi Health | Stevens, Dane | CEO | 15-Jul-26 | 448,847 | NT |
Stock Chart
Related Companies to Explore
Company Info
Optimi Health Corp. (NASDAQ: OPTH · CSE: OPTI · FSE: 8BN) produces finished-dose psilocybin and MDMA capsules for regulated therapeutic use. The Company operates a Health Canada GMP-compliant facility in Princeton, British Columbia, and holds a Drug Establishment Licence authorizing commercial manufacture, packaging, testing, and international export of controlled drug products. Active supply operations began under the Australian Authorized Prescriber Scheme in 2024. Product is dispensed to patients through authorized clinics for post-traumatic stress disorder and treatment-resistant depression.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.